Insider Shareholders with Direct Ownership of Hcw Biologics Inc. (HCWB)
This section provides a comprehensive overview of the insiders with direct ownership of Hcw Biologics Inc. (HCWB). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
HCW Biologics Inc. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Hing C Wong
Chief Executive Officer |
11,864,996 | 0 | 501,911 $3.88 Million | 20 |
May 16, 2025
Added 1.58%
|
Peter Rhode
Officer |
43,215 | 0 | 77,500 $599,075 | 4 |
Dec 11, 2023
Added 15.3%
|
Jin An Jiao
VP of Development |
24,570 | 0 | 45,141 $348,939 | 2 |
May 31, 2022
Added 3.66%
|
Rebecca Byam
Chief Financial Officer |
1,363,371 | 0 | 43,010 $332,467 | 34 |
May 08, 2025
Added 16.44%
|
35,715 | 0 | 35,815 $276,849 | 1 |
Feb 20, 2024
Added 49.93%
|
|
18,808 | 0 | 25,505 $197,153 | 2 |
May 16, 2025
Added 34.48%
|
|
Lee Flowers
SVP of Business Development |
154,773 | 0 | 5,720 $44,215 | 9 |
May 08, 2025
Added 14.4%
|
13,150 | 0 | 4,075 $31,499 | 16 |
May 16, 2025
Added 24.77%
|
|
45,087 | 0 | 2,066 $15,970 | 4 |
May 08, 2025
Added 31.77%
|
|
Medmira Capital Ltd.
> 10% Shareholder |
3,587,661 | 3,587,659 | 0 $0 | 2 |
Sep 15, 2021
Reduced 100.0%
|